Comparison of the efficacy and safety of direct-acting antiviral therapy with or without hepatitis C-related hepatocellular carcinoma.

Conclusions: DAA treatment efficacy in CHC patients with or those without HCC were not significantly different, and HCC recurrence was relatively common.
PMID: 32241083 [PubMed - as supplied by publisher]

Source: The Korean Journal of Internal Medicine - April 2, 2020 Category: Internal Medicine Authors: Kwan BS, Kim JH, Park SJ, Choe WH, Kwon SY, Yoo BC Tags: Korean J Intern Med Source Type: research